Inhaled Saline
Showing 1 - 25 of 4,518
COPD Exacerbation, COPD Exacerbation Trial (Furosemide, Normal saline)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease Exacerbation
- COPD Exacerbation
- Furosemide
- Normal saline
- (no location specified)
Mar 3, 2023
One-lung Ventilation, COPD Trial in Seoul (5ml of inhaled normal saline, 2.5mg (2.5ml) of inhaled salbutamol and 2.5ml of
Recruiting
- One-lung Ventilation
- Chronic Obstructive Pulmonary Disease
- 5ml of inhaled normal saline
- 2.5mg (2.5ml) of inhaled salbutamol and 2.5ml of inhaled normal saline
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Jun 13, 2023
Vomiting, Nausea, Children, Only Trial in Buffalo (Inhaled Isopropyl Alcohol, Oral Ondansetron, Inhaled Placebo)
Recruiting
- Vomiting
- +2 more
- Inhaled Isopropyl Alcohol
- +2 more
-
Buffalo, New YorkOishei Children's Hospital
Jun 12, 2022
Acute Pharyngitis Trial in Muscat (Budesonide 0.25 MG/ML Inhalant Solution, Dexamethasone, Normal saline)
Completed
- Acute Pharyngitis
- Budesonide 0.25 MG/ML Inhalant Solution
- +2 more
-
Muscat, Oman
- +2 more
Jul 6, 2022
Nausea Trial in Calgary, Edmonton, Wimborne (Isopropyl alcohol, Placebo)
Recruiting
- Nausea
- Isopropyl alcohol
- Placebo
-
Calgary, Alberta, Canada
- +4 more
Aug 3, 2022
Right Heart Failure, Right Ventricular Dysfunction Trial (Combined Epoprostenol Sodium & Milrinone, Normal saline)
Not yet recruiting
- Right Heart Failure
- Right Ventricular Dysfunction
- Combined Epoprostenol Sodium & Milrinone
- Normal saline
- (no location specified)
Jul 5, 2022
Interstitial Lung Disease Trial in Kingston (Fentanyl Citrate, Placebo)
Completed
- Interstitial Lung Disease
- Fentanyl Citrate
- Placebo
-
Kingston, Ontario, CanadaRespiratory Investigation Unit, Queen's University
Apr 21, 2022
Bronchiectasis Adult, Pseudomonas Aeruginosa Infection Trial in China (Tobramycin Inhalant Product, Ciprofloxacin 750 MG, Oral
Recruiting
- Bronchiectasis Adult
- Pseudomonas Aeruginosa Infection
- Tobramycin Inhalant Product
- +3 more
-
Shanghai, Shanghai, China
- +59 more
Oct 16, 2023
Mediastinal Mass Trial in Seoul (5ml of inhaled normal saline, 20µg (2ml) of inhaled iloprost (Ventavis®) and 3ml of inhaled
Not yet recruiting
- Mediastinal Mass
- 5ml of inhaled normal saline
- 20μg (2ml) of inhaled iloprost (Ventavis®) and 3ml of inhaled normal saline
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Jun 9, 2021
Pneumonia, Hypoxemia, Acute Respiratory Failure Trial in United States (Inhaled budesonide and formoterol, Inhaled )
Recruiting
- Pneumonia
- +3 more
- Inhaled budesonide and formoterol
- Inhaled placebo
-
Birmingham, Alabama
- +11 more
Aug 8, 2022
Transient Tachypnea of the Newborn Trial (Epinephrine Inhalation Solution, Salbutamol, Saline Inhalants)
Completed
- Transient Tachypnea of the Newborn
- Epinephrine Inhalation Solution
- +2 more
- (no location specified)
Aug 7, 2021
Healthy Trial in Hannover (RLS-0071 (10 mg/kg intravenously every 8 hours for total of 3 doses), RLS-0071 (loading dose of 120
Recruiting
- Healthy
- RLS-0071 (10 mg/kg intravenously every 8 hours for total of 3 doses)
- +2 more
-
Hannover, GermanyFraunhofer Institute for Toxicology and Experimental Medicine (I
May 25, 2022
Tuberculosis Trial in Oxford, Birmingham, London (Aerosol inhaled MVA85A, Intramuscular MVA85A, Intramuscular Saline )
Terminated
- Tuberculosis
- Aerosol inhaled MVA85A
- +3 more
-
Oxford, Oxfordshire, United Kingdom
- +4 more
Aug 14, 2020
Nausea Trial in San Antonio (Inhaled isopropyl alcohol, Oral ondansetron, Inhaled normal saline)
Completed
- Nausea
- Inhaled isopropyl alcohol
- +3 more
-
San Antonio, TexasSan Antonio Military Medical Center
Jul 12, 2020
Oxytocin, Pain, Empathy Trial in Beijing (Oxytocin nasal spray, Placebo, Stranger)
Not yet recruiting
- Oxytocin
- +4 more
- Oxytocin nasal spray
- +3 more
-
Beijing, Beijing, ChinaPeking University People's Hospital
Apr 8, 2023
Moderate to Severe Asthma Trial in Chapel Hill (3% Hypertonic Saline, 7% Hypertonic Saline)
Recruiting
- Moderate to Severe Asthma
- 3% Hypertonic Saline
- 7% Hypertonic Saline
-
Chapel Hill, North CarolinaCenter for Environmental Medicine, Asthma and Lung Biology
Jan 4, 2022
Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterium Infection Trial in New York, Portland, Toronto
Recruiting
- Nontuberculous Mycobacterial Lung Disease
- Nontuberculous Mycobacterium Infection
- Hypertonic saline
- +3 more
-
New York, New York
- +2 more
Jan 27, 2023
Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder) Trial in Los Angeles (MBS-COV, Placebo)
Recruiting
- Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)
- MBS-COV
- Placebo
-
Los Angeles, CaliforniaPhase I Unit
Jan 10, 2023
SARS-CoV 2, COVID, ARDS Trial (ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or Placebo)
Withdrawn
- SARS-CoV 2
- +5 more
- ZYESAMI™ (aviptadil acetate)
- +2 more
- (no location specified)
Feb 2, 2023
Acute Bronchiolitis Trial in Mardan (3% normal saline, steroid(beclomethasone dipropionate 400 µg/day) and salbutamol with 0.9%
Completed
- Acute Bronchiolitis
- 3% normal saline
- steroid(beclomethasone dipropionate 400 μg/day) and salbutamol with 0.9% normal saline
-
Mardan, Kpk, PakistanFaizan Sadiq
Nov 17, 2023
Bronchiectasis Trial in Kuala Lumpur (Nebulized 5% Hypertonic saline, Placebo)
Recruiting
- Bronchiectasis
- Nebulized 5% Hypertonic saline
- Placebo
-
Kuala Lumpur, Lembah Pantai, MalaysiaUniversity Malaya Medical Centre
May 16, 2022
SARS-CoV 2, COVID, ARDS Trial in United States (ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or
Terminated
- SARS-CoV 2
- +5 more
- ZYESAMI™ (aviptadil acetate)
- +2 more
-
Fullerton, California
- +12 more
Feb 2, 2023
Non Cystic Fibrosis Bronchiectasis Trial in Worldwide (Colistimethate Sodium, Saline Solution)
Completed
- Non Cystic Fibrosis Bronchiectasis
- Colistimethate Sodium
- Saline Solution
-
Adelaide, Australia
- +84 more
Aug 3, 2021